Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | HGF | 68.0 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | HGF | 71.0 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | HGF | 67.0 | 67 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | HGF | 73.5 | 46 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | HGF | 62.0 | 75 | |
RA2159 | Leptin | 1 | ng/mL | 1 | HGF | 51.0 | 73 | ||||
RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | HGF | 43.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | HGF | 48.0 | 69 | |
RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | HGF | 36.0 | 70 | |
RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | HGF | 40.0 | 40 | |
RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | HGF | 37.0 | 41 | |
N2586 | Leptin | 1 | ng/mL | 1 | HGF | 54.0 | 35 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | HGF | 51.5 | 46 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | HGF | 41.0 | 54 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | HGF | 55.0 | 38 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | HGF | 57.0 | 36 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | HGF | 52.5 | 46 | |
RA2159 | 1 | HGF | 0 | ||||||||
RA2159 | PD184352 | 0.1 | uM | 1 | HGF | 0 | |||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | HGF | 0 | |||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | HGF | 0 | |||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | HGF | 0 | |||||
RA2159 | IKK16 | 2.0 | uM | 1 | HGF | 0 | |||||
RA2159 | 1 | HGF | 0 | ||||||||
N2586 | 1 | HGF | 0 |